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Lower extremity arterial revascularization
in obese patients
Virendra I. Patel, MD, Allen D. Hamdan, MD, Marc L. Schermerhorn, MD, Chantel Hile, MD,
Suzanne Dahlberg, PhD, David R. Campbell, MD, Frank W. LoGerfo, MD,
and Frank B. Pomposelli, MD, Boston, Mass
Background: Obesity and associated comorbidities are associated with a high rate of complications and technical
difficulties after a number of surgical procedures. We studied the role of obesity in outcomes in lower extremity arterial
revascularization.
Methods: We reviewed all lower extremity arterial revascularizations performed at our institution in 2000. Body mass
index (BMI) greater than or equal to 30 kg/m2 defined obesity. Perioperative outcomes, long-term survival, and graft
patency were evaluated in obese and nonobese patients by using linear regression, the Fisher exact test, and Kaplan-Meier
analysis.
Results: The study population consisted of 74 (26%) obese and 207 (74%) nonobese patients. Patient demographics of the
obese and nonobese populations were similar. The mean BMI for obese patients was 35  5 kg/m2 and in nonobese
patients was 25  3 kg/m2. The mean age of each group was 67  10 years (BMI >30 kg/m2) and 70  13 years (BMI
<30 kg/m2). There were 45 (61%) obese men and 29 (39%) obese women. There were 128 (62%) nonobese men and 79
(38%) nonobese women. Diabetes was present in 76% of the obese and 70% of the nonobese patients. Perioperative
myocardial infarction, 30-day mortality, and rate of reoperation within 30 days were not significantly different. Obese
patients had higher increased postoperative wound infection rates (16% vs 7%; P  .04). Survival analysis showed 81% 
5% and 85%  3% 1-year survival and 66%  6% and 62%  3% 3-year survival in obese and nonobese patients (P  .58),
respectively. Kaplan-Meier estimates showed no effect of obesity on long-term graft patency, with 1-year graft patency
rates of 82%  6% and 81%  4% in obese and nonobese patients, respectively (P  .79).
Conclusions:Obese patients have similar limb salvage rates, perioperative cardiac morbidity, long-term survival rates, and
long-term graft patency but have increased perioperative wound infections. ( J Vasc Surg 2007;46:738-42.)Obesity is an increasing problem in the United
States.1,2 Obesity is thought by many to increase the tech-
nical difficulty of surgical procedures and to have a major
effect on the postoperative care of surgical patients. There
has been limited evaluation of the effect of obesity on
surgical outcomes.3-6 Obese patients undergoing coronary
arterial bypass grafting have been shown to have similar
long-term survival and graft patency; however, they have
increased perioperative wound morbidity when compared
with nonobese patients.3,4 The aim of our study was to
evaluate the role of obesity on outcomes in lower extremity
arterial revascularization.
Obesity is defined by using body mass index (BMI),
calculated as weight (kilograms) divided by the square of
height (meters). BMI is the most commonly used parame-
ter to describe obesity. The National Institutes of Health
has defined overweight as a BMI of 25 to 29.9 kg/m2 and
obesity as a BMI greater than 30 kg/m2. Obesity is further
divided into class I (BMI 30-34.9 kg/m2), class II (BMI
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73835-39.9 kg/m2), and class III, or morbid, obesity (BMI
40 kg/m2).7 For the purpose of this work, obesity and
morbid obesity will be defined in accordance with the
National Heart, Lung and Blood Institute classification.
Obesity is an epidemic in the United States population,
whose trends have been studied through surveys conducted
by the Centers for Disease Control and Prevention and the
National Center for Health Statistics. These studies have
shown that the overall prevalence of obesity has increased
from 13.3% to 30.9% and that that of morbid obesity has
increased from 2.9% to 4.7% since 1980.2 Obesity is asso-
ciated with significant comorbidities, including diabetes,
hypertension, hypercholesterolemia, and an increased risk
of death.8-10 These comorbidities are assumed to have
untoward affects on surgical outcomes in obese patients.
No study to date has been undertaken to evaluate the
role of obesity on surgical outcomes in vascular surgery.
Obesity poses technical difficulty in the performance of
lower extremity revascularization and compounds many of
the comorbidities of peripheral vascular disease. This
prompted us to hypothesize that obese patients undergo-
ing lower extremity arterial revascularization would have
similar long-term survival and increased perioperative
wound complication rates in comparison to nonobese pa-
tients.
METHODS
We retrospectively reviewed the medical records of
patients who underwent lower extremity arterial revascular-
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January 1, 2000, to December 31, 2000. Patient data were
entered prospectively into a computerized vascular registry
at the time of surgery. A board-certified vascular surgeon
who was assisted by a resident performed all procedures.
This study was approved by the Institutional Review Board
at Beth Israel Deaconess Medical Center and included 294
adult patients who underwent 318 infrainguinal revascular-
ization procedures. Data were incomplete for 13 patients,
thus resulting in 281 patients for survival analysis.
Demographic data and perioperative risk factors
evaluated for our study included age, sex, diabetes,
smoking, coronary artery disease, congestive heart fail-
ure (CHF), angina, hypertension, arrhythmia, previous
myocardial infarction, renal disease, creatinine 2.0
mg/dL, hemodialysis, operative time, and perioperative
fluid balances. Technical factors studied included the
indication for the procedure, level of distal anastomosis,
and type of conduit used for bypass. Postoperative com-
plications were prospectively entered into the registry by
staff, fellows, residents, or support staff. Postoperative
complications evaluated for this study included graft
thrombosis, wound hematoma, lymphocele, wound in-
fection, wound dehiscence, graft infection, CHF, renal
failure, pneumonia, arrhythmia, sepsis, urinary tract in-
fection, nerve injury, deep venous thrombosis, pulmo-
nary embolus, 30-day reoperation, 30-day mortality,
length of stay, and postoperative length of stay. Long-
term outcomes studied were ipsilateral amputation rate,
long-term survival, and long-term graft patency. Height,
weight, and social security numbers were extracted by
retrospective review of all medical records. Long-term
survival data from the Social Security Mortality Database
were gathered by using patient social security numbers.
BMI was calculated by dividing a patient’s weight
(kilograms) by the square of their height (meters). BMI
categories were divided into nonobese (BMI 30 kg/m2)
and obese (BMI 30 kg/m2) according to the National
Heart, Lung and Blood Institute obesity classification. All
demographic data are presented as percentage prevalence in
the study populations. All mean data are presented as
mean  SD. Statistical analysis was performed by linear
regression of BMI as a predictor against all demographic
and outcome variables. The results of the linear regression
were verified by using the Fisher exact test. Kaplan-Meier
estimation of the survival distribution was performed for
the obese and nonobese groups from the date of operation
to the date of death. Long-term graft patency and amputa-
tion rates were evaluated by Kaplan-Meier analysis. The
log-rank test for the equality of the survival distribution
curves was used to evaluate for differences in long-term
survival and graft patency. All statistical analyses were per-
formed by a statistician using the statistical software R
version 2.0.1 (public domain software free download).
Results with a P value of .05 were considered statistically
significant.RESULTS
The study population consisted of 294 patients. Com-
plete height, weight, and survival data were available for
281 (96%). There were 74 (25%) obese and 207 (75%)
nonobese patients in the study population. The mean BMI
in nonobese patients was 25  3 kg/m2, and the mean
BMI for obese patients was 35 5 kg/m2. The BMI of the
entire population showed a near-normal distribution (Fig
1), with a mean BMI of 27  6 kg/m2.
The obese patients were younger (67  10 years) than
nonobese patients (70  13 years; P  .03). The obese
population was composed of 62% men and 38% women. The
nonobese population was similar, with 61% men and 39%
women (not significant). Diabetes was prevalent in 70% of
obese patients and 76% of nonobese patients (not significant).
Overall the demographics of the two study groups were sim-
ilarwith respect to prevalence of diabetes, insulin use, smoking
status, coronary artery disease, CHF, renal disease, creatinine
greater than 2, and a history of renal transplantation (Table I).
There was a trend toward decreased age, decreased hemodi-
alysis use, and increased incidenceof hypertension in theobese
population (Table I).
Intraoperative characteristics of the study groups
showed no significant differences. The indications for lower
extremity arterial revascularization in obese patients were
claudication (9%), limb ischemia (38%), rest pain (5%),
infection (19%), gangrene (26%), and nonhealing ulcer
(3%). The indications for surgery in nonobese patients were
claudication (6%), limb ischemia (34%), rest pain (6%),
infection (17%), gangrene (33%), and nonhealing ulcer
Fig 1. Distribution of body mass index (BMI). This histogram
shows the frequency of BMI found throughout the study popula-
tion. The number over each bar is the number of patients with that
BMI. The mean BMI is 27  6 kg/m2.(3%) (not significant). The overall case length was similar in
JOURNAL OF VASCULAR SURGERY
October 2007740 Patel et alobese and nonobese patients (Table II). The technical
aspects of the procedures performed showed a similar inci-
dence of redo operations and level of distal anastomosis
(Table II). The conduit used for revascularization was
similar in both groups of patients (Table II). There were no
differences in the rates of postoperative graft thrombosis,
hemorrhage, wound hematoma, wound dehiscence, lym-
phocele, CHF, renal failure, graft infection, urinary tract
infection, pneumonia, sepsis, deep venous thrombosis, pul-
monary embolus, or nerve injury between groups (Table
III). There was a trend toward increased postoperative
arrhythmia (8% in the obese group vs 3% in the nonobese
group; P  .09), total length of stay (11  12 days vs 9 
Table I. Demographics and comorbidities of the study
population
Variable
P
value
Nonobese
(BMI 30 kg/m2)
(n  207)
Obese
(BMI 30 kg/m2)
(n  74)
Age (y) .03 70  13 67  10
Male NS 128 (62%) 45 (61%)
Female NS 79 (38%) 29 (39%)
Diabetes NS 145 (70%) 56 (76%)
Insulin use NS 95 (46%) 40 (54%)
Smoker NS 34 (16%) 14 (19%)
Coronary disease NS 112 (54%) 41 (55%)
Congestive heart
failure NS 45 (22%) 17 (23%)
Hypertension .07 145 (70%) 60 (81%)
Renal disease NS 51 (25%) 15 (20%)
Creatinine 2 NS 35 (17%) 7 (10%)
Renal transplant NS 6 (3%) 3 (4%)
Hemodialysis .09 23 (11%) 5 (6%)
BMI, Body mass index; NS, not significant.
Data are mean  SD or n (%).
Table II. Technical outcomes
Variable
P
value
Nonobese
(BMI 30 kg/m2)
(n  207)
Obese
(BMI 30 kg/m2)
(n  74)
Case length (d) NS 210  94 210  87
Claudication NS 12 (6%) 7 (9%)
Limb ischemia NS 73 (35%) 28 (38%)
Rest pain NS 12 (6%) 4 (5%)
Foot infection NS 35 (17%) 14 (19%)
Gangrene NS 69 (33%) 19 (26%)
Nonhealing
ulcer NS 6 (3%) 2 (3%)
Redo operation NS 38 (18%) 12 (16%)
Saphenous vein NS 144 (70%) 53 (72%)
Arm vein NS 31 (15%) 10 (14%)
PTFE NS 32 (15%) 4 (5%)
Bypass to
popliteal NS 67 (32%) 27 (37%)
Bypass below
popliteal NS 140 (68%) 27 (64%)
BMI, Body mass index; NS, not significant; PTFE, polytetrafluoroethylene.
Data are mean  SD or n (%).7 days; P  .06), and postoperative length of stay (8  11day vs 6 5 days; P .09) in obese individuals (Table III).
Postoperative wound infection rates (16% vs 7%; P  .04;
odds ratio, 2.4; 95% confidence interval, 1.02-5.6) were
significantly increased in obese patients (Table III).
Major perioperative complications—including death,
myocardial infarction, and 30-day reoperative rates—were
similar between the two groups (Table IV). There was no
difference in long-term survival for obese and nonobese
individuals (Fig 2). One-year survival rates in obese and
nonobese patients were 81%  5% and 85%  3%, respec-
tively. Three-year survival rates were 66% 6% and 62%
3% in obese and nonobese individuals (P .6). Long-term
graft patency rates were similar in obese and nonobese
individuals (Fig 3). One-year graft patency rates were
82%  6% and 81%  4%, and 3-year graft patency rates
were 62%  9% and 64%  5% in obese and nonobese
patients (P .8). Ipsilateral amputation rates were 14% and
12% in obese and nonobese patients, respectively (not
Table III. Postoperative outcomes
Variable
P
value
Nonobese
(BMI 30 kg/m2)
(n  207)
Obese
(BMI 30 kg/m2)
(n  74)
Postoperative
length of stay (d) .09 6  5 8  11
Length of stay (d) .06 9  7 11  12
Graft thrombosis NS 7 (3%) 3 (4%)
Hemorrhage NS 3 (1%) 3 (4%)
Wound hematoma NS 22 (11%) 5 (7%)
Wound infection .04 15 (7%) 12 (16%)
Wound dehiscence NS 4 (2%) 2 (3%
Lymphocele NS 0 0
Congestive heart
failure NS 4 (2%) 2 (3%)
Renal failure NS 3 (1%) 2 (3%)
Graft infection NS 0 3 (4%)
Urinary infection NS 1 (0.5%) 2 (3%)
Pneumonia NS 1 (0.5%) 0
Sepsis NS 0 0
Deep vein
thrombosis NS 0 0
Pulmonary
embolus NS 0 0
Nerve injury NS 0 0
Arrhythmia .09 6 (3%) 6 (8%)
BMI, Body mass index; NS, not significant.
Data are mean  SD or n (%).
Table IV. Major complications
Variable
Nonobese
(BMI 30 kg/m2)
(n  207)
Obese
(BMI 30 kg/m2)
(n  74)
30-d myocardial
infarction 5 (2%) 1 (1%)
30-d mortality 3 (1%) 0
30-d reoperation 16 (8%) 11 (15%)
BMI, Body mass index.
Data are n (%).significant; Fig 4).
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Our study population had a normal distribution of
BMI, and the mean of 27  6 kg/m2 was consistent with
obesity trends in other studies. The actual percentage of
obese patients (26%) in our population is reflective of the
national average of 30.9%, but it is increased from the local
and regional rates of 16.1% in Massachusetts and 16.9% in
New England. Our center specializes in lower extremity
arterial revascularization and the treatment of diabetic foot
Fig 2. Kaplan-Meier curves plotting the fraction of the study
population alive over time. The solid line represents survival in
nonobese patients, and the dashed line represents the survival of
obese patients. Arrows delineate where the standard deviation of
the curve exceeds 10%. BMI, Body mass index.
Fig 3. Kaplan-Meier curves plotting the fraction of graft patency
over time. The solid line represents graft patency in the nonobese
group, and the dashed line represents graft patency in obese pa-
tients. Arrows delineate where the standard deviation of the curve
exceeds 10%. BMI, Body mass index.ulcers.11 This increase in obesity relative to the local prev-alence may be attributed to selection bias secondary to
referral patterns from a major diabetes specialty hospital.
Our study, similar to others, used BMI as a measure of
obesity. We divided our patient population into obese and
nonobese according to the National Heart, Lung and
Blood Institute guidelines for the definition of obesity
(BMI 30 kg/m2). Obesity subclass evaluation of our
population resulted in 53 class I, 12 class II, and 9 class III
obesity patients. Kaplan-Meier survival curves were gener-
ated for the obesity subclasses, and no survival differences
were noted among the four groups (data not shown). We
were not able to subclassify patients into class I, II, or III
and meaningfully evaluate the outcomes given the high
likelihood of type II error.
Obese patients were similar to nonobese patients with
regard to demographic characteristics. Diabetes was equally
prevalent in both groups, and both groups had similar rates
of insulin use for blood sugar control. This similarity
among groups is different from that reported by Birkmeyer
et al3 and Kim et al4 and is likely attributable to the large
diabetic population treated at our institution.
Wound infections were increased in obese patients with
an odds ratio of 2.4 (95% confidence interval, 1.02-5.56).
Wound infections were defined as any infection of the
surgical incision which required an alteration in manage-
ment, such as starting antibiotics, opening a wound, or
debriding a wound. The increased infection rate in obese
patients may be attributed to technical factors; however,
the indications for revascularization, use of the saphenous
vein as a conduit, and the complexity of bypasses was similar
in both groups. Our center does not perform incision
limiting or laparoscopic saphenous vein harvest. The use of
incision-limiting techniques may decrease wound length
Fig 4. Amputation-free survival. Kaplan-Meier curves plotting
the fraction of patients undergoing major amputation over time.
The solid line represents freedom from amputation in the nonobese
group, and the dashed line represents freedom from amputation in
obese patients. BMI, Body mass index.and the extent of tissue dissection and may decrease wound
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techniques in obese patients. We did not evaluate the
effectiveness of glycemic control in the perioperative set-
ting, but all postoperative patients undergoing surgery at
our institution are aggressively treated with insulin and oral
hyperglycemic agents to maintain fingerstick blood glucose
levels of 80 to 120 mg/dL. Increased insulin resistance and
relative hyperglycemia may have accounted for the higher
wound infection rates found in obese patients. Alterations
in surgical technique and in postoperative management of
obese patients may improve infection rates and warrant
further study.
Long-term outcomes in obese patients were similar to
those of nonobese patients undergoing lower extremity revas-
cularization. Long-term survival was similar in both groups.
Long-term graft patency rates were also similar in obese and
nonobese patients. Limb salvage as assessed by the ipsilateral
amputation rate was also similar in both groups. The results of
our study echo similar studies performed on patients under-
going cardiac surgery. Kim et al4 showed that obese patients
had perioperative morbidity and mortality rates similar to
those of nonobese patients and had similar 5-year survival
curves. In that study, obese patients were also more prone to
perioperative sternal infections.
The incidence of obesity is increasing in theUnited States;
therefore, it will continue to be an increasing problem in
surgery. Surgical outcomes in obese patients have been eval-
uated by a limited number of studies, includingours.3-6 In our
study, obese patients did not have increased perioperative
mortality or myocardial infarction rates. We have shown that
obese patients have long-term survival, graft patency, and limb
salvage similar to those of nonobese individuals. Surgical
outcomes in obese patients are most notable for an increased
risk of wound infections. Obese patients undergoing lower
extremity revascularization should be closely monitored for
signs and symptoms of wound infection.
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